These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33069561)

  • 21. Do medical marijuana laws increase marijuana use? Replication study and extension.
    Harper S; Strumpf EC; Kaufman JS
    Ann Epidemiol; 2012 Mar; 22(3):207-12. PubMed ID: 22285867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid Death Rate Acceleration in Jurisdictions Legalizing Marijuana Use-Reply.
    Bradford AC; Abraham A; Bagwell Adams G
    JAMA Intern Med; 2018 Sep; 178(9):1281-1282. PubMed ID: 30193247
    [No Abstract]   [Full Text] [Related]  

  • 23. Marijuana Decriminalization, Medical Marijuana Laws, and Fatal Traffic Crashes in US Cities, 2010-2017.
    Cook AC; Leung G; Smith RA
    Am J Public Health; 2020 Mar; 110(3):363-369. PubMed ID: 31944840
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescription opioid misuse, sources of opioids and reasons for opioid misuse among reproductive aged parenting women with major depressive episode.
    Sanmartin MX; Ali MM; Chen J; Dwyer DS
    Addict Behav; 2019 Nov; 98():106057. PubMed ID: 31376658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of medical marijuana laws on cannabis-involved driving.
    Sevigny EL
    Accid Anal Prev; 2018 Sep; 118():57-65. PubMed ID: 29885927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical and Non-Medical Opioid Use at the Intersection of Gender and Sexual Identity: Associations with State Medical Cannabis Law Status in a U.S. National Sample of Adults.
    Mauro PM; Philbin MM; Greene ER; Askari MS; Martins SS
    Arch Sex Behav; 2021 Nov; 50(8):3551-3561. PubMed ID: 34751862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sources and Main Motivations for Prescription Opioid Misuse Among Reproductive-Aged Parenting Women in the United States.
    Sanmartin MX; Ali MM; Novak P; Chen J
    Subst Use Misuse; 2019; 54(8):1332-1336. PubMed ID: 30860931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of cannabis in response to the opioid crisis: A review of the literature.
    Vyas MB; LeBaron VT; Gilson AM
    Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder.
    Segura LE; Mauro CM; Levy NS; Khauli N; Philbin MM; Mauro PM; Martins SS
    JAMA Netw Open; 2019 Jul; 2(7):e197216. PubMed ID: 31314118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical and non-medical cannabis use and risk of prescription opioid use disorder: Findings from propensity score matching.
    Liang D; Wallace MS; Shi Y
    Drug Alcohol Rev; 2019 Sep; 38(6):597-605. PubMed ID: 31347204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
    Phillips E; Gazmararian J
    J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis use, attitudes, and legal status in the U.S.: A review.
    Carliner H; Brown QL; Sarvet AL; Hasin DS
    Prev Med; 2017 Nov; 104():13-23. PubMed ID: 28705601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. United States marijuana legalization and opioid mortality epidemic during 2010-2020 and pandemic implications.
    Bleyer A; Barnes B; Finn K
    J Natl Med Assoc; 2022 Aug; 114(4):412-425. PubMed ID: 35469600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study.
    De Aquino JP; Sofuoglu M; Stefanovics EA; Rosenheck RA
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):812-822. PubMed ID: 33035104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking, vaping, eating: Is legalization impacting the way people use cannabis?
    Borodovsky JT; Crosier BS; Lee DC; Sargent JD; Budney AJ
    Int J Drug Policy; 2016 Oct; 36():141-7. PubMed ID: 26992484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges.
    Saunders JB; Jarlenski MP; Levy R; Kozhimannil KB
    Womens Health Issues; 2018; 28(2):130-136. PubMed ID: 29183818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata.
    Ali MM; McClellan C; Mutter R; Rees DI
    Health Econ; 2023 Feb; 32(2):277-301. PubMed ID: 36335085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. State Medical Marijuana Laws and Associated Marijuana Use, Attitudes, and Perceived Social Norms among Adolescents in the U.S.
    Wong SW; Buu A; Lin HC
    J Psychoactive Drugs; 2020; 52(5):383-392. PubMed ID: 32723036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between marijuana use and nonmedical prescription opioid use in the United States: are we shifting from one epidemic to another?
    Arora P; Johnson A; Jayasekare R; Desai K
    J Public Health Policy; 2021 Jun; 42(2):310-321. PubMed ID: 33879832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmedical Use of Prescription Opioids among Pregnant U.S. Women.
    Kozhimannil KB; Graves AJ; Levy R; Patrick SW
    Womens Health Issues; 2017; 27(3):308-315. PubMed ID: 28408072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.